HJ

Hiren Jitendrakumar Mori

Active Director Director DIN 11495744
DIN 11495744 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Hiren Jitendrakumar Mori

Data last updated:

Hiren Jitendrakumar Mori is a Director at Amberg Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11495744
Primary Designation Director
Industry Pharma
First Appointment 20 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jan 20262026Active

Board colleagues of Hiren Jitendrakumar Mori

Directorship timeline

Open interactive timeline →
Amberg Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hiren Jitendrakumar Mori

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hiren Jitendrakumar Mori

Hiren Jitendrakumar Mori currently holds 1 directorship: Amberg Pharmaceuticals Private Limited (Director, since 20 Jan 2026).

Hiren Jitendrakumar Mori was first appointed on 20 Jan 2026 as Director at Amberg Pharmaceuticals Private Limited.

The current boards of Hiren Jitendrakumar Mori's companies include Dashrathbhai Jethiram Agravat (Amberg Pharmaceuticals Private Limited), Divyaben Jitendrakumar Mori (Amberg Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available